Abstract
One of the key issues in fighting the current pandemic, or the ones to come, is to obtain objective quantitative indicators of the effectiveness of the measures taken to contain the epidemic. The aim of this work is to point out that the lag between the daily number of infections and casualties provides one such indicator. For this we determined the lag during the first phase of the Covid-19 pandemic for a series of countries using the data available at the server of the John Hopkins University using three different methods. Somewhat surprisingly, we find a lag varying substantially between countries, taking negative values (thus the maximum daily number of casulties preceding the maximum daily namber of new infections) in countries where no steps to contain the epidemic have been taken at the outset, with an average lag of 7 ± 0.3 days. Our results can be useful to health authorities in a search for the best strategy to fight the epidemic.
Key Messages
The lags between the maximum daily infections and casualties during the first phase of the Covid-19 pandemic differ widely between countries.
These lags are clear for some countries, but impossible to determine confidently for most.
In some countries the day at which the maximal number of daily deaths is attained precedes the day of the maximal number of casualties, indicating a failure to protect the most vulnerable part of the population.
The lags can serve as an objective quantitative measure of the effectiveness of the measures taken to contain the epidemic.
Competing Interest Statement
There are no competing interests
Funding Statement
No exterior funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No approval needed
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data publicly available on the server of the John Hopkins University
